2m 2m 2m 2m 2m 2m 2m
Medtronic (MDT)
NYSE
$79.60-$0.53 (-0.66%)
Price as of Jun 25, 2026 4:54 AM EDT- $103.2BMarket Cap
- -3.83%1-Year Change
- Medical DevicesIndustry
Medtronic (MDT)
$79.60-$0.53 (-0.66%)
Annual
Quarterly
04/24/2026 | 04/25/2025 | 04/26/2024 | 04/28/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 36.4B +8.43% | 33.5B +3.62% | 32.4B +3.64% | 31.2B -1.45% | |
Cost of Revenue | 12.7B +9.36% | 11.6B +3.71% | 11.2B +4.64% | 10.7B +5.66% | |
Gross Profit | 23.6B +7.93% | 21.9B +3.58% | 21.1B +3.12% | 20.5B -4.80% | |
Sales and Marketing Expense | 11.8B +8.62% | 10.8B +1.05% | 10.7B +3.08% | 10.4B +1.20% | |
Research and Development Expense | -2.9B +5.16% | -2.7B -0.11% | -2.7B +1.45% | -2.7B -1.82% | |
Depreciation and Amortization Expense | 3.0B +3.39% | 2.9B +8.08% | 2.6B -1.85% | 2.7B -0.37% | |
Total Operating Expenses | 12.7B +9.36% | 11.6B +3.71% | 11.2B +4.64% | 10.7B +5.66% | |
Operating Profit | 6.5B +8.60% | 6.0B +15.77% | 5.1B -6.22% | 5.5B -4.64% | |
Interest Income | 45.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -715.0M -1.92% | -729.0M +1.39% | -719.0M +13.05% | -636.0M +15.01% | |
Interest Income and Expense and Net | -670.0M -8.09% | -729.0M +1.39% | -719.0M +13.05% | -636.0M +15.01% | |
Total Nonoperating Income and Expense | 384.0M -4.48% | 402.0M -2.43% | 412.0M -20.00% | 515.0M +61.95% | |
Income before Taxes | 6.1B +9.03% | 5.6B +16.35% | 4.8B -9.82% | 5.4B -2.77% | |
Income Taxes | 1.3B +38.78% | 936.0M -17.39% | 1.1B -28.29% | 1.6B +246.49% | |
Extraordinary Items | 0 N/A | 0 -100.00% | 371.0M N/A | 0 -100.00% | |
Net Income | 4.8B +2.98% | 4.7B +26.82% | 3.7B -2.18% | 3.8B -25.42% | |
Net Income from Continuing Operations Applicable to Common | 6.1B +9.03% | 5.6B +16.35% | 4.8B -9.82% | 5.4B -2.77% | |
Basic EPS and Net Income | 3.75 +3.31% | 3.63 +31.05% | 2.77 -2.12% | 2.83 -24.53% | |
Diluted EPS and Net Income | 3.73 +3.32% | 3.61 +30.80% | 2.76 -2.13% | 2.82 -24.40% | |
Basic Weighted Average Shares | 1.3B -0.30% | 1.3B -3.17% | 1.3B -0.16% | 1.3B -0.94% | |
Diluted Weighted Average Shares | 1.3B -0.14% | 1.3B -3.03% | 1.3B -0.20% | 1.3B -1.38% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.9B -12.13% | 2.2B +72.74% | 1.3B -16.79% | 1.5B -58.45% | |
Short-Term Investments | 7.3B +7.77% | 6.7B +0.39% | 6.7B +4.75% | 6.4B -6.46% | |
Cash and Cash Equivalents and Short-Term Investments | 9.2B +2.84% | 9.0B +11.99% | 8.0B +0.58% | 8.0B -24.72% | |
Total Current Assets | 24.8B +4.09% | 23.8B +8.57% | 21.9B +1.20% | 21.7B -6.00% | |
Accumulated Depreciation | 9.7B +10.80% | 8.8B +11.07% | 7.9B -6.72% | 8.5B +6.80% | |
Property and Plant and Equipment and Net | 7.4B +8.48% | 6.8B +11.52% | 6.1B +10.09% | 5.6B +2.88% | |
Total Long-Term Assets | 4.1B +15.71% | 3.6B -11.44% | 4.0B +2.22% | 4.0B +31.62% | |
Total Assets | 93.0B +1.47% | 91.7B +1.89% | 90.0B -1.06% | 90.9B -0.04% | |
Income Taxes Payable | 2.8B -16.31% | 3.3B -9.96% | 3.7B -5.22% | 3.9B +6.34% | |
Total Short-Term Debt | 1.8B -37.79% | 2.9B +163.19% | 1.1B +5,360.00% | 20.0M -99.47% | |
Total Current Liabilities | 11.7B -9.48% | 12.9B +19.37% | 10.8B +19.20% | 9.1B -26.97% | |
Total Long-Term Debt | 26.2B +2.07% | 25.6B +7.15% | 23.9B -1.69% | 24.3B +19.50% | |
Total Long-Term Liabilities | 2.1B +16.17% | 1.8B +29.60% | 1.4B -20.96% | 1.7B +22.48% | |
Total Liabilities | 43.0B -1.08% | 43.4B +9.76% | 39.6B +0.71% | 39.3B +2.67% | |
Retained Earnings | 32.6B +3.69% | 31.5B +3.53% | 30.4B +0.04% | 30.4B +0.47% | |
Total Stockholders Equity | 49.5B +3.00% | 48.0B -4.36% | 50.2B -2.46% | 51.5B -2.03% | |
Total Shares Outstanding | 1.3B -0.14% | 1.3B -2.24% | 1.3B -1.46% | 1.3B +0.005% | |
Cash Flow | |||||
Cash from Operating Activities | 7.3B +4.06% | 7.0B +3.79% | 6.8B +12.39% | 6.0B -17.79% | |
Capital Expenditures | 1.9B +2.42% | 1.9B +17.14% | 1.6B +8.77% | 1.5B +6.65% | |
Cash from Investing Activities | -2.9B +51.47% | -1.9B -18.13% | -2.4B -32.26% | -3.5B +110.55% | |
Dividends Paid | 3.6B +1.39% | 3.6B -2.10% | 3.7B +1.38% | 3.6B +6.89% | |
Cash from Financing Activities | -4.8B +8.94% | -4.4B -2.00% | -4.5B -10.28% | -5.0B -7.05% | |
Financials Ratio | |||||
Gross Margin | 65.02% -0.46% | 65.32% -0.04% | 65.34% -0.50% | 65.67% -3.40% | |
Operating Margin | 17.78% +0.16% | 17.76% +11.72% | 15.89% -9.51% | 17.56% -3.24% | |
Return on Assets | 5.20% +1.28% | 5.13% +26.31% | 4.06% -1.64% | 4.13% -24.55% | |
Return on Equity | 9.85% +3.78% | 9.49% +31.29% | 7.23% +0.07% | 7.22% -25.46% | |
Revenue Growth | 8.43% +132.58% | 3.62% -0.46% | 3.64% +351.35% | -1.45% -127.81% | |
Current Ratio | 2.13 +14.99% | 1.85 -9.05% | 2.03 -15.10% | 2.39 +28.72% | |
Cash Ratio | 0.17 -2.90% | 0.17 +44.71% | 0.12 -30.21% | 0.17 -43.11% | |
Debt-to-Equity Ratio | 0.57 -4.80% | 0.59 +19.17% | 0.50 +5.30% | 0.47 +3.12% | |
Debt-to-Assets Ratio | 0.30 -3.34% | 0.31 +11.83% | 0.28 +3.81% | 0.27 +1.09% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow